Membrane Protein-Based Immunoassay Development Service

    Membrane Protein-Based Immunoassay Development Service involves the expression, refolding, purification, and stability control of recombinant or naturally derived membrane proteins, ensuring the preservation of critical epitopes and native conformations. These structurally intact membrane proteins are then used for downstream applications such as antibody recognition, ligand binding, and immunoassay development.

     

    membrane-protein-based-immunoassay-development-service1.png

    García-González. et al. Practical Laboratory Medicine. 2016.

    Figure 1. Examples of immunoassay formats.

     

    Immunoassay is a class of bioanalytical techniques based on the specific recognition between antigens and antibodies. It is widely used in disease diagnosis, biomarker validation, vaccine development, and immunogenicity assessment. Common types of immunoassays include enzyme-linked immunosorbent assay (ELISA), surface plasmon resonance (SPR), and chemiluminescent immunoassay (CLIA). These techniques rely on the high-affinity binding between target molecules and antibodies, coupled with highly sensitive signal amplification and detection.

     

    Membrane proteins are proteins embedded in or associated with the cell membrane, accounting for over 30% of all human protein-coding genes. They serve as key mediators of cellular communication and environmental signal exchange. Due to their critical biological functions, membrane proteins are highly valuable targets in both antibody drug development and immunoassay applications. A Membrane Protein-Based Immunoassay refers to an assay system that uses membrane proteins as antigens or targets, primarily for applications such as antibody screening, specificity validation, pharmacokinetic analysis, vaccine research, and quality control.

     

    MtoZ Biolabs offers Membrane Protein-Based Immunoassay Development Service enabling clients to obtain high-quality membrane protein antigens and supporting the development of highly specific and sensitive immunoassay platforms. These solutions are applicable to drug development, biomarker validation, immunogenicity studies, and quality assurance in biopharmaceutical research.

     

    Analysis Workflow

    The main workflow of Membrane Protein-Based Immunoassay Development Service is as follows:

     

    1. Target Membrane Protein Selection and Design

    Define the intended assay target and select appropriate membrane protein domains or full-length constructs.

     

    2. Membrane Protein Expression and Purification

    Utilize a suitable expression system and purification techniques (e.g., affinity chromatography) to obtain conformationally intact membrane proteins.

     

    3. Antigen Optimization and Validation

    Perform concentration gradient optimization, functional validation, and conformational integrity assessment based on client requirements.

     

    4. Immunoassay Platform Development Support

    Provide method development assistance for immunoassay platforms, including affinity validation and assay optimization.

     

    5. Data Analysis and Result Delivery

    Deliver comprehensive reports including antigen characterization, functional activity validation, and immunoassay compatibility assessment.

     

    Service Advantages

    1. Conformation Integrity: Utilizes optimized expression systems and membrane-mimetic refolding strategies to ensure native conformation and functional activity of membrane proteins.

    2. Multi-Platform Compatibility: Fully compatible with major immunoassay formats including ELISA, SPR, and CLIA.

    3. Flexible Customization: Supports domain trimming, tag customization, and antigen optimization tailored to specific project needs.

    4. One-Time-Charge: Our pricing is transparent, no hidden fees or additional costs.

    5. Advanced Platform: MtoZ Biolabs established an advanced Membrane Protein-Based Immunoassay Development Service platform, guaranteeing reliable, fast, and highly accurate service.

     

    Applications

    Application examples of Membrane Protein-Based Immunoassay Development Service:

    • Monoclonal/polyclonal antibody screening and specificity validation.
    • Pharmacokinetic and immunogenicity analysis of antibody-based therapeutics.
    • Development of diagnostic assays for disease biomarkers.
    • Construction of detection systems for membrane protein-targeting drugs.
    • Quality control and process analysis in biopharmaceutical development.

     

    Related Services

    Membrane and Membrane Protein Extraction Service

    Membrane Protein Structure Determination Service

    Membrane Protein-Molecule Interaction Analysis Service

Submit Inquiry
Name *
Email Address *
Phone Number
Inquiry Project
Project Description *

 

How to order?


/assets/images/icon/icon-message.png

Submit Inquiry

/assets/images/icon/icon-return.png